Probolic SR
Natural health product licensed in Canada
- Licence holder
- Maximum Human Performance
- NPN or DIN-HM
- 80052309
- Status
- Active licence
- Licence date
- 8 July 2014
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Borago officinalis Source : Semence(s) Potency : 10 % gamma-Linolenic acid | Not specified | Not calculated |
| Borago officinalis Source : Semence(s) | 200 mg | Not calculated |
| Linum usitatissimum Source : Graine(s) | 200 mg | Not calculated |
| Oenothera biennis Source : Graine(s) | 200 mg | Not calculated |
| Oenothera biennis Source : Graine(s) Potency : 4.8 % gamma-Linolenic acid | Not specified | Not calculated |
| Caséinate de calcium Source : Calcium caseinate | 5.6 g | Not calculated |
| L-Leucine Source : L-Leucine | 200 mg | Not calculated |
Non-medicinal ingredients
Amidon alimentaire, modifié, Acide DL-malique, Gomme de xanthane, Lécithine, Huile de tournesol, Acide citrique, Acide lactique, Gélatine, Saveur de fraise, Carraghénine, Dioxyde de silicium, Chlorure de sodium, NA, Gomme de cellulose, Acide stéarique, Saveur de crème, Sucralose, Maltodextrine, Tocophérols, Acésulfame potassium, Ascorbate de sodium, Poudre de cacao, Betterave rouge, Saveur de banane, Vanille
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Mesures ; maximum: 2 Mesures | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Whey protein concentrate and soy protein isolates are sources of protein, which helps build strong muscles. Whey protein concentrate is a source of protein which helps build and repair body tissues. Whey protein concentrate is a source of protein which helps build antibodies. L-leucine, L-valine, and L-isoleucine are essential amino acids involved in protein synthesis. A source of magnesium, which helps to maintain proper muscle function. Whey protein concentrate is a source of protein for the maintenance of good health. Whey protein is a source of amino acids involved in muscle protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
This product contains sodium. Consult a health care practitioner prior to use if you are taking blood thinners, following a low-protein diet, or if you are taking other medications/natural health products. Consult a health care practitioner prior to use if you have a liver or kidney disorder, high blood pressure, Parkinson's disease, or if you develop liver related symptoms (e.g. abdominal pain, jaundice, dark urine). Consult a health care practitioner prior to use if you are obese or have cardiovascular disease (CVD) risk factors (e.g. high blood pressure, high cholesterol and/or triglycerides).
- Contre-indications
Do not use if you are pregnant, breastfeeding, have a milk allergy, or are taking Levodopa, a medication used to treat Parkinson's disease. Do not use if you have CVD, diabetes, metabolic syndrome or insulin resistance.
- Effets indésirables connus
This product may cause mild gastrointestinal disturbances/discomfort, rashes, muscle ache, and dry lips. Hypersensitivity, such as an allergy, has been known to occur in rare cases; in which case, discontinue use.
Source
Official Health Canada record, licence 80052309
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.